Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer. 2016 Sep 15;122(18):2918-24. doi: 10.1002/cncr.30133. Epub 2016 Jul 25.
The frequency of delirium among patients with cancer presenting to the emergency department (ED) is unknown. The purpose of this study was to determine delirium frequency and recognition by ED physicians among patients with advanced cancer presenting to the ED of The University of Texas MD Anderson Cancer Center.
The study population was a random sample of English-speaking patients with advanced cancer who presented to the ED and met the study criteria. All patients were assessed with the Confusion Assessment Method (CAM) to screen for delirium and with the Memorial Delirium Assessment Scale (MDAS) to measure delirium severity (mild, ≤15; moderate, 16-22; and severe, ≥23). ED physicians were also asked whether their patients were delirious.
Twenty-two of the 243 enrolled patients (9%) had CAM-positive delirium, and their median MDAS score was 14 (range, 9-21 [30-point scale]). The median age of the enrolled patients was 62 years (range, 19-89 years). Patients with delirium had a poorer performance status than patients without delirium (P < .001); however, the 2 groups did not differ in other characteristics. Ten of the 99 patients who were 65 years old or older (10%) had CAM-positive delirium, whereas 12 of the 144 patients younger than 65 years (8%) did (P = .6). According to the MDAS scores, delirium was mild in 18 patients (82%) and moderate in 4 patients (18%). Physicians correctly identified delirium in 13 of the CAM-positive delirious patients (59%).
Delirium is relatively frequent and is underdiagnosed by physicians in patients with advanced cancer who are visiting the ED. Further research is needed to identify the optimal screening tool for delirium in ED. Cancer 2016. © 2016 American Cancer Society. Cancer 2016;122:2918-2924. © 2016 American Cancer Society.
癌症患者在急诊科(ED)就诊时发生谵妄的频率尚不清楚。本研究的目的是确定在德克萨斯大学 MD 安德森癌症中心 ED 就诊的晚期癌症患者发生谵妄的频率和 ED 医生对其的识别情况。
研究人群为随机抽取的英语流利、符合入组标准的晚期癌症就诊 ED 的患者。所有患者均接受意识模糊评估法(CAM)筛查谵妄,采用谵妄评定量表(MDAS)评估谵妄严重程度(轻度:≤15 分;中度:16-22 分;重度:≥23 分)。ED 医生还被询问其患者是否存在谵妄。
243 例入组患者中有 22 例(9%)为 CAM 阳性谵妄,其 MDAS 评分中位数为 14 分(范围:9-21 分[30 分制])。入组患者的中位年龄为 62 岁(范围:19-89 岁)。谵妄患者的表现状态比无谵妄患者差(P<0.001);但 2 组患者在其他特征方面无差异。99 例年龄≥65 岁的患者中有 10 例(10%)为 CAM 阳性谵妄,而 144 例年龄<65 岁的患者中有 12 例(8%)为 CAM 阳性谵妄(P=0.6)。根据 MDAS 评分,18 例(82%)患者为轻度谵妄,4 例(18%)患者为中度谵妄。CAM 阳性谵妄的 13 例患者中,医生正确识别出 11 例(59%)。
在 ED 就诊的晚期癌症患者中,谵妄较为常见,但医生对其诊断不足。需要进一步研究以确定 ED 中谵妄的最佳筛查工具。癌症 2016;122:2918-2924。©2016 美国癌症协会。癌症 2016;122:2918-2924。©2016 美国癌症协会。